FAP– CHO K1 Recombinant Cell Line (High, Medium or Low Expression)

Only %1 left
Catalog #
As low as $7,510 *

Cat # Size Price*

*US Pricing only. For international pricing, please contact your local distributor.

Recombinant FAP-CHO K1 cell line stably expressing a full length human FAP-alpha protein (Genbank accession No: NM004460.2). Surface expression of FAP was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of FAP expression (High, Medium, or Low) to mimic different stages of cancer target cells with various FAP expression levels.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

FAP-alpha cell line, Fibroblast activation protein alpha cell line, prolyl endopeptidase FAP cells
Product Info
Storage and Usage
Host Cell Line
Supplied As
Each vial contains ~ 2 x 106 cells in 1 ml of 10% DMSO in FBS.
Genbank #
UniProt #
Mycoplasma Testing

This cell line has been screened using the MycoAlert™ Mycoplasma Detection Kit (Lonza, #LT07-118) to confirm the absence of Mycoplasma contamination. MycoAlert Assay Control Set (Lonza, #LT07-518) was used as a positive control.


Fibroblast activation protein alpha (FAP-alpha) belongs to the dipeptidyl peptidase IV (DPP4; CD26) gene family and is a cell-surface serine protease that acts on various hormones and extracellular matrix components. FAP expression under physiological conditions is scarce in healthy adult tissues. But FAP gene is highly upregulated in a wide variety of cancers, and is often used as a marker for pro-tumorigenic stroma. It has also been proposed as a molecular target of cancer therapies, and a great deal of research has gone into design and testing of diverse FAP-targeted treatments.